Related Experiment Video
Updated: Aug 5, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
Successes and Opportunities during the Pandemic: Reflections and Revelations from a Vaccine Development Perspective
Penny M Heaton1, Kavitha Palaniappan2, Anne-Claire Stona2
1The Janssen Pharmaceutical Companies of Johnson & Johnson, Singapore, Singapore.
The Centre of Regulatory Excellence (CoRE) established an annual lecture series to honor Professor Sir Alasdair Breckenridge. The 2022 lecture emphasized trust, collaboration, and transparency in healthcare and vaccine development.
Area of Science:
- Biomedical science
- Regulatory science
- Global health policy
Background:
- The Centre of Regulatory Excellence (CoRE) initiated an annual lecture series in 2021.
- The series honors Professor Sir Alasdair Breckenridge, CoRE's founding Chair.
- The lectures aim to foster dialogue on global biomedical and regulatory issues.
Purpose of the Study:
- To highlight successes and opportunities in pandemic response and management.
- To share insights from leading experts in the biomedical and public health sectors.
- To promote discussion on critical factors influencing healthcare and vaccine production.
Main Methods:
- The 2022 Sir Alasdair Breckenridge Lecture was delivered by Dr. Penny M. Heaton.
- Dr. Heaton's presentation focused on "Success and Opportunities in the Pandemic."
- Key lessons were drawn from her extensive experience in global health and vaccine development.
Main Results:
- Dr. Heaton underscored the critical importance of trust in healthcare systems and public health initiatives.
- Collaboration among international organizations, governments, and private sectors was identified as a key success factor.
- Transparency in communication and processes was highlighted as essential for effective pandemic response and vaccine production.
Conclusions:
- Building and maintaining public trust is paramount for effective healthcare delivery and vaccine acceptance.
- Enhanced collaboration and transparent practices are crucial for navigating global health challenges.
- The lecture series serves as a vital platform for advancing regulatory science and global health dialogue.
More Related Videos
07:04Optimization of In vitro Transcription Reaction for mRNA Production Using Chromatographic At-Line Monitoring
Published on: April 4, 2025
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Preclinical Development: Overview
Vaccinations
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...